S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
A gold storm is coming… (Ad)
Why a new Alzheimer's drug is having a slow US debut
Sri Lanka marks independence anniversary amid economic woes
A gold storm is coming… (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
A gold storm is coming… (Ad)
Why a new Alzheimer's drug is having a slow US debut
Sri Lanka marks independence anniversary amid economic woes
A gold storm is coming… (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
A gold storm is coming… (Ad)
Why a new Alzheimer's drug is having a slow US debut
Sri Lanka marks independence anniversary amid economic woes
A gold storm is coming… (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
State of the Union: Biden sees economic glow, GOP sees gloom
A gold storm is coming… (Ad)
Why a new Alzheimer's drug is having a slow US debut
Sri Lanka marks independence anniversary amid economic woes
A gold storm is coming… (Ad)
Tesla hikes price of Model Y after US alters tax credit rule
Disney World unions vote down offer covering 45,000 workers
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
NASDAQ:STAA

STAAR Surgical - STAA Stock Forecast, Price & News

$77.97
-1.37 (-1.73%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$76.59
$79.43
50-Day Range
$46.82
$79.34
52-Week Range
$46.35
$112.27
Volume
453,165 shs
Average Volume
789,718 shs
Market Capitalization
$3.76 billion
P/E Ratio
102.59
Dividend Yield
N/A
Price Target
$82.70

STAAR Surgical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.90 Rating Score
Upside/​Downside
6.1% Upside
$82.70 Price Target
Short Interest
Bearish
9.83% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.73
Upright™ Environmental Score
News Sentiment
0.48mentions of STAAR Surgical in the last 14 days
Based on 12 Articles This Week
Insider Trading
Acquiring Shares
$4.36 M Bought Last Quarter
Proj. Earnings Growth
24.10%
From $0.83 to $1.03 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.40 out of 5 stars

Medical Sector

185th out of 1,028 stocks

Ophthalmic Goods Industry

2nd out of 7 stocks

STAA stock logo

About STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Stock News Headlines

Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
STAAR Surgical (NASDAQ:STAA) PT Raised to $80.00
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Needham Keeps Their Buy Rating on Staar Surgical (STAA)
Needham Reaffirms Their Hold Rating on Sight Sciences (SGHT)
STAAR Surgical Company Updates FY23 Net Sales Outlook
7 Analysts Have This to Say About Staar Surgical
See More Headlines
Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Company Calendar

Last Earnings
11/03/2021
Today
2/04/2023
Next Earnings (Estimated)
2/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:STAA
CUSIP
85231230
Employees
692
Year Founded
1982

Price Target and Rating

Average Stock Price Forecast
$82.70
High Stock Price Forecast
$125.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+6.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

Net Income
$24.50 million
Pretax Margin
16.66%

Debt

Sales & Book Value

Annual Sales
$230.47 million
Cash Flow
$0.67 per share
Book Value
$5.43 per share

Miscellaneous

Free Float
46,953,000
Market Cap
$3.76 billion
Optionable
Optionable
Beta
1.18

Social Links


Key Executives

  • Thomas G. Frinzi
    Chairman, President & Chief Executive Officer
  • Patrick F. WilliamsPatrick F. Williams
    Chief Financial Officer & Vice President
  • Keith HollidayKeith Holliday
    Chief Technology Officer
  • Scott D. Barnes
    Chief Medical Officer
  • Samuel J. GestenSamuel J. Gesten
    Secretary & Chief Legal Officer













STAA Stock - Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STAA shares.
View STAA analyst ratings
or view top-rated stocks.

What is STAAR Surgical's stock price forecast for 2023?

10 equities research analysts have issued 1 year target prices for STAAR Surgical's shares. Their STAA share price forecasts range from $60.00 to $125.00. On average, they expect the company's stock price to reach $82.70 in the next twelve months. This suggests a possible upside of 6.1% from the stock's current price.
View analysts price targets for STAA
or view top-rated stocks among Wall Street analysts.

How have STAA shares performed in 2023?

STAAR Surgical's stock was trading at $48.54 at the beginning of the year. Since then, STAA stock has increased by 60.6% and is now trading at $77.97.
View the best growth stocks for 2023 here
.

When is STAAR Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our STAA earnings forecast
.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings data on Wednesday, November, 3rd. The medical instruments supplier reported $0.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.11 by $0.01. The medical instruments supplier had revenue of $58.35 million for the quarter, compared to analysts' expectations of $57.70 million. STAAR Surgical had a trailing twelve-month return on equity of 15.13% and a net margin of 13.54%. During the same period in the prior year, the firm posted $0.14 earnings per share.

What guidance has STAAR Surgical issued on next quarter's earnings?

STAAR Surgical updated its FY 2022 earnings guidance on Monday, January, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $284.00 million-$284.00 million, compared to the consensus revenue estimate of $285.35 million.

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees.

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Baillie Gifford & Co. (10.87%), Defender Capital LLC. (1.04%), APEIRON CAPITAL Ltd (0.70%), Hodges Capital Management Inc. (0.34%), Kornitzer Capital Management Inc. KS (0.31%) and Ziegler Capital Management LLC (0.24%). Insiders that own company stock include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten.
View institutional ownership trends
.

How do I buy shares of STAAR Surgical?

Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $77.97.

How much money does STAAR Surgical make?

STAAR Surgical (NASDAQ:STAA) has a market capitalization of $3.76 billion and generates $230.47 million in revenue each year. The medical instruments supplier earns $24.50 million in net income (profit) each year or $0.76 on an earnings per share basis.

How many employees does STAAR Surgical have?

The company employs 692 workers across the globe.

Does STAAR Surgical have any subsidiaries?
The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.
Read More
How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962.

This page (NASDAQ:STAA) was last updated on 2/5/2023 by MarketBeat.com Staff